These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 33909462)
21. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis. Lim Z; Gu TY; Tai BC; Puhaindran ME World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic Performance of MRI in the Detection of Renal Lipid-Poor Angiomyolipomas: A Systematic Review and Meta-Analysis. Wilson MP; Patel D; Murad MH; McInnes MDF; Katlariwala P; Low G Radiology; 2020 Sep; 296(3):511-520. PubMed ID: 32602827 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Broski SM; Johnson GB; Howe BM; Nathan MA; Wenger DE; Spinner RJ; Amrami KK Skeletal Radiol; 2016 Aug; 45(8):1097-105. PubMed ID: 27115884 [TBL] [Abstract][Full Text] [Related]
24. Investigation of Ultrasound Parameters for the Differential Diagnosis of Malignant and Benign Peripheral Nerve Sheath Tumors. Jin Z; Zhao K; Guo W; Wang D; Deng Y; Chen T J Ultrasound Med; 2022 Dec; 41(12):3091-3101. PubMed ID: 36082840 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of dual-energy CT for the detection of bone marrow edema in the appendicular skeleton: a systematic review and meta-analysis. Wilson MP; Lui K; Nobbee D; Murad MH; McInnes MDF; McGrath TA; Katlariwala P; Low G Eur Radiol; 2021 Mar; 31(3):1558-1568. PubMed ID: 32901304 [TBL] [Abstract][Full Text] [Related]
26. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. Friedrich RE; Kluwe L; Fünsterer C; Mautner VF Anticancer Res; 2005; 25(3A):1699-702. PubMed ID: 16033085 [TBL] [Abstract][Full Text] [Related]
27. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1. Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076 [TBL] [Abstract][Full Text] [Related]
28. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature. Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382 [TBL] [Abstract][Full Text] [Related]
29. Association between benign and malignant peripheral nerve sheath tumors in NF1. Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787 [TBL] [Abstract][Full Text] [Related]
31. Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Schmidt H; Taubert H; Meye A; Würl P; Bache M; Bartel F; Holzhausen HJ; Hinze R Cancer Lett; 2000 Jul; 155(2):181-90. PubMed ID: 10822134 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors. Nonaka D; Chiriboga L; Rubin BP J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346 [TBL] [Abstract][Full Text] [Related]
33. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion. Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623 [TBL] [Abstract][Full Text] [Related]
35. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center. Graham DS; Russell TA; Eckardt MA; Motamedi K; Seeger LL; Singh AS; Bernthal NM; Kalbasi A; Dry SM; Nelson SD; Elashoff D; Levine BD; Eilber FC Am J Clin Oncol; 2019 Oct; 42(10):739-743. PubMed ID: 31436746 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI. Reinert CP; Schuhmann MU; Bender B; Gugel I; la Fougère C; Schäfer J; Gatidis S Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):776-787. PubMed ID: 30535768 [TBL] [Abstract][Full Text] [Related]
37. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis. Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697 [TBL] [Abstract][Full Text] [Related]
38. Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Mautner VF; Friedrich RE; von Deimling A; Hagel C; Korf B; Knöfel MT; Wenzel R; Fünsterer C Neuroradiology; 2003 Sep; 45(9):618-25. PubMed ID: 12898075 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of dual-energy CT for detecting bone marrow edema in patients with acute knee injuries: a systematic review and meta-analysis. Wilson MP; Lui K; Nobbee D; Murad MH; Katlariwala P; Low G Skeletal Radiol; 2021 May; 50(5):871-879. PubMed ID: 33090251 [TBL] [Abstract][Full Text] [Related]
40. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]